Professor Lieven Annemans
Ghent University, Ghent (Belgium)
Follow
Contributor content
Journal
‘Highest risk–highest benefit’ strategy: a pragmatic, cost-effective approach to targeting use of PCSK9 inhibitor therapies
11 December 2017
Journal
Health economic evaluation of controlled and maintained physical exercise in the prevention of cardiovascular and other prosperity diseases
1 December 2007
